PROLONGATION OF RED‐CELL LIFE‐SPAN BY INCORPORATION OF DECAY‐ACCELERATING FACTOR (DAF) INTO RED CELLS OF PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA (PNH)
Open Access
- 1 September 1989
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 73 (1) , 132-133
- https://doi.org/10.1111/j.1365-2141.1989.tb00234.x
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Decay‐accelerating factor (DAF) on the blood cell membranes in patients with paroxysmal nocturnal haemoglobinuria (PNH): measurement by enzyme‐linked immunosorbent assay (ELISA)British Journal of Haematology, 1988
- Paroxysmal nocturnal hemoglobinuria type III. Lack of an erythrocyte membrane protein restricting the lysis by C5b-9.Journal of Clinical Investigation, 1987
- Deficiency of the homologous restriction factor in paroxysmal nocturnal hemoglobinuria.The Journal of Experimental Medicine, 1987
- Amelioration of lytic abnormalities of paroxysmal nocturnal hemoglobinuria with decay-accelerating factor.Proceedings of the National Academy of Sciences, 1985
- Affected erythrocytes of patients with paroxysmal nocturnal hemoglobinuria are deficient in the complement regulatory protein, decay accelerating factor.Proceedings of the National Academy of Sciences, 1983
- Recommended Methods for Radioisotope Red‐Cell Survival Studies* A REPORT BY THE ICSH PANEL ON DIAGNOSTIC APPLICATIONS OF RADIOISOTOPES IN HAEMATOLOGYBritish Journal of Haematology, 1971